Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

NCT00168779 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1185

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: telmisartan 80 mg / hydrochlorothiazide 25 mg
DRUG: valsartan 160 mg / hydrochlorothiazide 25 mg
DRUG: placebo

Sponsor

Boehringer Ingelheim